We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Database Giants Announce Strategic Partnership

By Biotechdaily staff writers
Posted on 20 Feb 2007
Genomatix Software GmbH (Munich, Germany) and Molecular Connections Private Ltd., (Bangalore, India) recently announced the formation of a strategic partnership in the field of biotechnology information management. More...


Genomatix employs a multi-layer integrative approach that combines sequence analysis, functional promoter analysis, proprietary genome annotation, promoter sequence databases, comparative genomics, scientific literature data mining, pathway databases, biologic network databases, pathway analysis, network analysis, and expression profiling. Molecular Connections provides text mining, literature curation, and annotation services as well as products. It claims specific expertise in building knowledge bases for rapidly growing genomics, proteomics, and related areas.

The new partnership will fully integrate Molecular Connections Netpro database into Genomatix's biologic networks and pathway knowledge base and analysis system BiblioSphere PathwayEdition (BSPE). Netpro is reputed to be one of the largest expert curated databases of protein-protein and protein-small molecule interactions in the world and contains highly granular contextual data on nature of interaction, pathways, diseases, location, plus pharmacokinetics information related to the interactions. BSPE's database is created from millions of individually modeled relationships between genes, proteins, complexes, cells, and tissues.

"I am absolutely delighted by this partnership with Molecular Connections,” said Dr. Thomas Werner, CEO of Genomatix. "By it we are able to combine the best of two worlds: large scale text mining and our expert knowledge of gene regulation with the unbeatable expert curation of Molecular Connection's expert scientists. In my eyes this is a perfect match. From all what I have seen, Molecular Connections adheres to the same rigorous quality standards as Genomatix does.”

Mr. Jignesh Bhate, CEO of Molecular Connections remarked, "We are happy to be associated with Genomatix. We believe NetPro will provide significant value to the existing and future users of BSPE.”





Related Links:
Genomatix Software GmbH
Molecular Connections Private Ltd.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.